Reports of Harmful Side Effects Linked to Weight Loss Drugs Continue to Rise

In this article Taylor Hampton Solicitors discuss the medical side effects and concerns of weight loss drugs. The popularity of weight loss injections such as Ozempic, Mounjaro, and Wegovy continues to grow. Nevertheless, so too does the conversation around their safety. Once reserved primarily for managing Type 2 diabetes, these medications are now widely promoted as weight loss solutions. Indeed, this is a shift that has brought with it new concerns and increasing scrutiny.

Clinicians are reporting a surge in patients presenting with complicationsand regulatory bodies are responding by launching investigations into potential risks. For many hoping to improve their figure or suffering from obesity, the promise of rapid weight loss may come with unexpected and serious side effects.

Growing Use, Growing Concerns with weight loss medication

In the UK alone, an estimated 1.5 million people are currently using weight loss drugs. That figure may be conservative, given the growing number of individuals sourcing these medications through unofficial or unregulated channels including social media platforms and overseas websites.

The NHS recently approved the wider rollout of Mounjaro, making it available to individuals classified as severely obese. As more people gain access to these drugs, the spotlight is turning to the risks associated with their use.

Clinicians have begun raising the alarm, noting an uptick in side effects ranging from digestive complications to reproductive health issues and vision problems. These developments have prompted the Medicines and Healthcare products Regulatory Agency (the MHRA) to step in.

MHRA Response and Investigations

The MHRA, which oversees the safety of medical products in the UK, allows clinicians and patients to report suspected side effects through its Yellow Card Scheme. In light of the increase in adverse event reports tied to weight loss drugs, the agency has now confirmed it will launch a new study to examine the issue in more depth.

Part of this study will evaluate whether current guidance and product labelling are sufficient. Should the evidence point to underreported risks, the MHRA may recommend clearer or more prominent warnings on packaging.

At present, for example, pancreatitis is classified as uncommon on Ozempics safety labelling. Yet, growing anecdotal evidence suggests it may be more prevalent than initially thought.

What Are the Side Effects?

The adverse effects being reported are varied and often serious. In the case of Mounjaro, a number of patients have experienced acute pancreatitiswhich is a painful and potentially dangerous inflammation of the pancreas. Symptoms include abdominal pain, nausea and vomiting. Moreover, in severe cases this may require hospitalisation.

Concerns have also been raised about reproductive health. In June, the MHRA issued an alert following reports of what some have called Ozempic babies. Ozempic babies are unplanned pregnancies potentially linked to the drugs interference with the contraceptive pills effectiveness. At the same time, some studies suggest these medications may carry risks of miscarriage and birth defects, although further research is needed to draw definitive conclusions.

Other reported complications include vision changes and blood clots, particularly among users of Ozempic and Wegovy. In the United States, these concerns have given rise to a wave of product liability lawsuits. Certainly patients alleged that manufacturers failed to adequately warn about these potential outcomes.

A Lack of Research for Weight Loss Use

While drugs like Ozempic, Wegovy, and Mounjaro have been around for years, they were originally developed to manage blood sugar levels in diabetic patients. Their repositioning as weight loss aids is relatively recent and that shift has created a noticeable research gap.

Because these medications were not initially studied in non-diabetic populations, theres a lack of robust long-term data on their safety when used solely for weight loss. As studies now begin to catch up, it is becoming clear that risks may vary depending on how and why the drug is used.

This is especially important for healthcare professionals, who must remain up to date with evolving evidence. Informed consent is essential. Patients must be fully aware of potential side effects before starting a course of treatment. If a clinician fails to provide this information or dismisses a known risk, they may be open to a claim of clinical negligence.

What You Should Do If Youve Experienced Side Effects

Anyone who has experienced unexpected complications after taking a weight loss medication should seek medical advice promptly. In some cases, patients may not have been properly warned about the potential risks, either by their clinician or on the products packaging.

If this has happened to you, and youre unsure what steps to take, its worth seeking expert legal advice. You may have grounds to pursue a claim, whether for medical negligence or product liability.

How We Can Help

At Taylor Hampton, we represent individuals in both product liability and medical negligence claims. We understand how distressing it can be to suffer an adverse reaction, particularly when youve placed your trust in a healthcare provider or a widely marketed treatment.

If youve been affected by any of the issues discussed above or if you have questions about whether you might have a claim, our team is here to support you. Whether youd like to explore your options or simply talk through your concerns, we invite you to get in touch for a confidential conversation.

Contact: enquiries@taylorhampton.co.uk or call +442074275970.